Reviewed by: the ADCES Professional Practice Committee. Updated by ADCES Staff.
Revised: January 25,2025
Continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy, is in its fifth decade of use and continues to grow in popularity. More recently, there has been an integration of continuous glucose monitoring (CGM) devices onto the pump screen and the creation of the first FDA approved insulin pump that responds to sensor data to adjust basal rates, suspend on low or impending low, and give automatic correction bolus doses when glucose is approaching pre-determined targets.
Automated insulin delivery systems are revolutionizing glucose management.1,2 The current data indicate there are over one million people with diabetes on insulin pump therapy worldwide3 and 350,000 to 515,000 in the United States.4 Insulin pump therapy offers increased lifestyle flexibility and improved glucose management.
Diabetes care and education specialists play an integral role in helping people with diabetes (PWD) achieve success in the use of insulin pump therapy, which has been demonstrated to improve clinical outcomes and quality of life.
Diabetes care and education specialists:
Explore our insulin pump section further to find topics that should be covered by diabetes care and education specialists when teaching people with diabetes and their families or significant others. Insulin pump therapy and the importance of maintaining a high level of expertise in this subspecialty of diabetes education if choosing to include pump and sensor training in the individual specialist’s practice are critical in diabetes management today.
References:
American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. ADCES Insulin Pump Therapy Guidelines, ISPAD Clinical Practice Consensus Guidelines 2022: Insulin Pump Therapy. Endocrine Society. Management of Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM). Clinical Research on Insulin Pumps & Automated Insulin Delivery (AID) Systems: Beck RW, Riddlesworth T, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. JAMA, 2017.
DISCLAIMERS:
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.